title: [Effect and safety of transrectal 137 CS gamma-rays in the treatment of benign prostatic hyperplasia].
abstract: OBJECTIVE
  To evaluate the effect and safety of transrectal 137Cs gamma-ray therapy for benign prostatic hyperplasia.
  
  
  METHODS
  Thirty cases of BPH were treated by transrectal 137Cs gamma-rays.
  
  
  RESULTS
  After 6 months there was significant improvement in the maximum urine flow, IPSS and QOL (P < 0.05). But no significant changes were observed in the prostate volume and residual urine (P > 0.05).
  
  
  CONCLUSIONS
  Transrectal 137Cs gamma-ray therapy is safe and effective in the treatment of BPH.
authors.affiliation: Department of Urology, the First Hospital of Peking University, Institute of Urology, Peking University, Beijing 100034, China.
authors.forename: Xin
authors.initials: X
authors.lastname: Li
authors.forename: Ning-chen
authors.initials: NC
authors.lastname: Li
authors.forename: Gang
authors.initials: G
authors.lastname: Wang
authors.forename: Yan-qun
authors.initials: YQ
authors.lastname: Na
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002588:Cesium Radioisotopes / Q000627:therapeutic use*; D005720:Gamma Rays / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000532:radiotherapy*; D011788:Quality of Life; D014563:Urodynamics
chemical_list: D002588:Cesium Radioisotopes